% Expired Patents = 50.0

EPO Patents = 3

Forward Citations = 294

Loading Chart...

9 inventors (with patents filed for the assignee):

Pingyu Zhong (6 out of 15 patents)

Caili Wang (5 out of 5 patents)

Xinwei Wang (4 out of 6 patents)

4. Peizhi Luo (4 out of 8 patents)

5. Shengfeng Li (2 out of 12 patents)

6. Mark Hsieh (2 out of 6 patents)

7. Shengjiang Liu (2 out of 2 patents)

8. Yan Li (1 out of 28 patents)

9. Kevin C Wang (1 out of 2 patents)

6 patents: Sort by Forward Citations

1. 7910350 - Adaptor-directed helper systems (2011-03-22),

2. 7667004 - Humanized antibodies against vascular endothelial growth factor (2010-02-23),

3. 7429652 - Compositions and methods for generating chimeric heteromultimers (2008-09-30),

4. 7175983 - Adapter-directed display systems (2007-02-13),

5. 7117096 - Structure-based selection and affinity maturation of antibody library (2006-10-03),

6. 6833441 - Compositions and methods for generating chimeric heteromultimers (2004-12-21),

Abmaxis, Inc. is a leading biotechnology company specializing in the development of therapeutic antibodies for various diseases. Our innovative approach and cutting-edge technology have allowed us to create a robust pipeline of potential treatments targeting cancer, autoimmune disorders, and infectious diseases. With a team of experienced scientists and industry experts, we are committed to advancing research and bringing novel therapies to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

6 Patents

#12 in Rahway, NJ

#1,670 in New Jersey

#44,871 in US

Rahway, NJ, United States of America

Abmaxis, Inc.